Direxion Daily S&P Biotech Bull 3X Shares
Direxion Shares ETF Trust
+29
New
-29
Exited
167
Positions
| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DREYFUS GOVERNMENT CASH MANAGE | N/A | Apr 2024 | 162,914,303 | +154,374,303 | $162.9M | +1807.7% | 27.02% | STIV |
| 2 | GOLDMAN FINANCIAL | N/A | Apr 2024 | 95,586,139 | New | $95.6M | — | 15.85% | STIV |
| 3 | DREYFUS | S99991620 | Apr 2024 | 31,366,143 | +12,896,143 | $31.4M | +69.8% | 5.20% | STIV |
| 4 | N/A | N/A | Apr 2024 | 1 | New | $26.8M | — | 4.45% | DE |
| 5 | GOLDMAN SACHS LIQ ES FD A | N/A | Apr 2024 | 18,721,150 | New | $18.7M | — | 3.10% | STIV |
| 6 | Alnylam Pharmaceuticals Inc. | ALNY | Apr 2024 | 40,332 | -7,489 | $10.6M | +54.2% | 1.76% | EC |
| 7 | Natera Inc. | NTRA | Apr 2024 | 67,698 | -12,760 | $10.2M | +36.7% | 1.69% | EC |
| 8 | Vertex Pharmaceuticals Incorporated | VRTX | Apr 2024 | 19,738 | +2,418 | $10.1M | +47.8% | 1.67% | EC |
| 9 | Neurocrine Biosciences Inc | NBIX | Apr 2024 | 89,666 | +38,206 | $9.7M | +36.4% | 1.60% | EC |
| 10 | United Therapeutics Corporation | UTHR | Apr 2024 | 31,842 | +2,362 | $9.7M | +39.7% | 1.60% | EC |
| 11 | Exact Sciences Corporation | EXAS | Apr 2024 | 211,014 | +91,672 | $9.6M | +36.0% | 1.60% | EC |
| 12 | Insmed Inc | INSM | Apr 2024 | 132,098 | -125,447 | $9.5M | +49.4% | 1.58% | EC |
| 13 | Gilead Sciences Inc. | GILD | Apr 2024 | 85,802 | -9,584 | $9.1M | +47.0% | 1.52% | EC |
| 14 | Amgen Inc. | AMGN | Apr 2024 | 31,296 | +5,121 | $9.1M | +27.0% | 1.51% | EC |
| 15 | Incyte Corporation. | INCY | Apr 2024 | 144,401 | +25,024 | $9.0M | +45.6% | 1.50% | EC |
| 16 | Madrigal Pharmaceuticals Inc | MDGL | Apr 2024 | 27,064 | -1,005 | $9.0M | +57.8% | 1.50% | EC |
| 17 | AbbVie Inc. | ABBV | Apr 2024 | 46,118 | +6,061 | $9.0M | +38.1% | 1.49% | EC |
| 18 | Regeneron Pharmaceuticals, Inc. | REGN | Apr 2024 | 14,180 | +6,784 | $8.5M | +28.9% | 1.41% | EC |
| 19 | Biogen Inc | BIIB | Apr 2024 | 69,754 | +37,660 | $8.4M | +22.5% | 1.40% | EC |
| 20 | Exelixis, Inc. | EXEL | Apr 2024 | 208,283 | -114,316 | $8.2M | +7.7% | 1.35% | EC |
| 21 | Blueprint Medicines Corporation | BPMC | Apr 2024 | 89,875 | +12,249 | $8.0M | +13.4% | 1.33% | EC |
| 22 | Moderna Inc | MRNA | Apr 2024 | 279,362 | +209,815 | $8.0M | +3.9% | 1.32% | EC |
| 23 | Biomarin Pharmaceutical Inc. | BMRN | Apr 2024 | 118,497 | +35,130 | $7.5M | +12.1% | 1.25% | EC |
| 24 | TG Therapeutics Inc | TGTX | Apr 2024 | 164,564 | -262,431 | $7.5M | +28.4% | 1.24% | EC |
| 25 | Bridgebio Pharma Inc | BBIO | Apr 2024 | 182,897 | -64,338 | $7.0M | +10.8% | 1.16% | EC |
| 26 | Halozyme Therapeutics Inc | HALO | Apr 2024 | 100,544 | -71,149 | $6.2M | -5.6% | 1.02% | EC |
| 27 | Revolution Medicines Inc | RVMD | Apr 2024 | 147,880 | -74,289 | $6.0M | -27.9% | 0.99% | EC |
| 28 | Cytokinetics Inc | CYTK | Apr 2024 | 133,450 | +24,476 | $5.7M | -14.4% | 0.95% | EC |
| 29 | Sarepta Therapeutics Inc | SRPT | Apr 2024 | 88,188 | +30,576 | $5.5M | -24.6% | 0.91% | EC |
| 30 | Roivant Sciences Ltd | ROIV | Apr 2024 | 448,569 | -222,301 | $5.2M | -28.7% | 0.86% | EC |
| 31 | CRISPR Therapeutics AG | CRSP | Apr 2024 | 132,141 | +41,353 | $5.1M | +6.2% | 0.85% | EC |
| 32 | Summit Therapeutics Inc. | SMMT | Apr 2024 | 207,887 | -300,182 | $5.0M | +151.1% | 0.83% | EC |
| 33 | Ionis Pharmaceuticals, Inc. | IONS | Apr 2024 | 159,478 | -3,397 | $4.9M | -27.1% | 0.81% | EC |
| 34 | Adma Biologics Inc | ADMA | Apr 2024 | 202,091 | -330,971 | $4.8M | +38.4% | 0.80% | EC |
| 35 | Viking Therapeutics Inc. | VKTX | Apr 2024 | 166,293 | +66,472 | $4.8M | -39.6% | 0.80% | EC |
| 36 | Springworks Therapeutics Inc | SWTX | Apr 2024 | 100,383 | -39,916 | $4.6M | -29.0% | 0.77% | EC |
| 37 | Avidity Biosciences Inc. | RNA | Apr 2024 | 131,050 | -25,965 | $4.3M | +12.9% | 0.71% | EC |
| 38 | Vaxcyte Inc | PCVX | Apr 2024 | 119,264 | +20,690 | $4.3M | -28.4% | 0.71% | EC |
| 39 | Alkermes PLC | ALKS | Apr 2024 | 136,131 | -108,825 | $3.9M | -34.8% | 0.65% | EC |
| 40 | Krystal Biotech Inc | KRYS | Apr 2024 | 21,872 | -19,831 | $3.7M | -41.8% | 0.62% | EC |
| 41 | Nuvalent Inc | NUVL | Apr 2024 | 46,320 | -38,580 | $3.6M | -39.2% | 0.59% | EC |
| 42 | Twist Bioscience Corporation | TWST | Apr 2024 | 89,835 | -100,875 | $3.4M | -42.2% | 0.57% | EC |
| 43 | Arcellx Inc | ACLX | Apr 2024 | 52,937 | -46,096 | $3.4M | -30.6% | 0.57% | EC |
| 44 | Rhythm Pharmaceuticals Inc | RYTM | Apr 2024 | 52,239 | -118,593 | $3.4M | -49.9% | 0.56% | EC |
| 45 | Scholar Rock Holding Corp. | SRRK | Apr 2024 | 101,052 | -169,092 | $3.3M | -16.1% | 0.55% | EC |
| 46 | N/A | N/A | Apr 2024 | 1 | New | $3.2M | — | 0.53% | DE |
| 47 | Soleno Therapeutics Inc | SLNO UR | Apr 2024 | 41,943 | -40,995 | $3.1M | -15.2% | 0.52% | EC |
| 48 | Ultragenyx Pharmaceuticals Inc | RARE | Apr 2024 | 80,362 | -61,428 | $3.1M | -48.1% | 0.52% | EC |
| 49 | Apellis Pharmaceuticals Inc | APLS | Apr 2024 | 163,008 | +46,740 | $3.1M | -39.1% | 0.52% | EC |
| 50 | Crinetics Pharmaceuticals Inc. | CRNX | Apr 2024 | 92,411 | -77,015 | $3.1M | -58.4% | 0.51% | EC |
| 51 | Veracyte Inc | VCYT | Apr 2024 | 100,407 | -140,672 | $3.1M | -35.1% | 0.51% | EC |
| 52 | Akero Therapeutics Inc | AKRO | Apr 2024 | 67,042 | -162,748 | $3.1M | -33.1% | 0.51% | EC |
| 53 | Recursion Pharmaceuticals Inc | RXRX | Apr 2024 | 541,499 | -98,804 | $3.0M | -39.5% | 0.50% | EC |
| 54 | Travere Therapeutics Inc | TVTX | Apr 2024 | 131,229 | -333,823 | $2.7M | +6.2% | 0.45% | EC |
| 55 | Acadia Pharmaceuticals Inc | ACAD | Apr 2024 | 181,230 | -124,443 | $2.6M | -48.2% | 0.44% | EC |
| 56 | PTC Therapeutics, Inc. | PTCT | Apr 2024 | 51,632 | -178,313 | $2.6M | -65.2% | 0.43% | EC |
| 57 | Agios Pharmaceuticals Inc | AGIO | Apr 2024 | 84,720 | -88,109 | $2.5M | -55.2% | 0.42% | EC |
| 58 | Arrowhead Pharmaceuticals Inc | ARWR | Apr 2024 | 174,443 | -39,754 | $2.4M | -50.0% | 0.40% | EC |
| 59 | Biohaven Ltd | BHVN | Apr 2024 | 108,308 | -15,285 | $2.4M | -50.0% | 0.40% | EC |
| 60 | Catalyst Pharmaceuticals Inc. | CPRX | Apr 2024 | 94,741 | -285,573 | $2.3M | -59.8% | 0.38% | EC |
| 61 | IDEAYA Biosciences Inc. | IDYA | Apr 2024 | 109,847 | -47,426 | $2.2M | -65.4% | 0.37% | EC |
| 62 | Syndax Pharmaceuticals Inc. | SNDX | Apr 2024 | 155,215 | -136,399 | $2.2M | -64.4% | 0.36% | EC |
| 63 | Arcutis Biotherapeutics Inc. | ARQT | Apr 2024 | 145,119 | -497,473 | $2.2M | -59.5% | 0.36% | EC |
| 64 | Beam Therapeutics Inc. | BEAM | Apr 2024 | 108,477 | -82,441 | $2.2M | -46.6% | 0.36% | EC |
| 65 | Celldex Therapeutics Inc. | CLDX | Apr 2024 | 98,019 | -51,534 | $2.0M | -63.5% | 0.34% | EC |
| 66 | Mirum Pharmaceuticals Inc. | MIRM | Apr 2024 | 46,931 | -161,103 | $2.0M | -61.0% | 0.34% | EC |
| 67 | Immunovant Inc | IMVT | Apr 2024 | 125,638 | -100,455 | $2.0M | -67.3% | 0.34% | EC |
| 68 | BioCryst Pharmaceuticals Inc. | BCRX | Apr 2024 | 229,227 | -997,247 | $2.0M | -60.0% | 0.34% | EC |
| 69 | Ardelyx Inc | ARDX | Apr 2024 | 356,011 | -468,495 | $2.0M | -62.9% | 0.33% | EC |
| 70 | Denali Therapeutics Inc | DNLI | Apr 2024 | 116,846 | -222,953 | $1.9M | -62.9% | 0.32% | EC |
| 71 | GRAIL Inc | GRAL | Apr 2025 | 55,102 | New | $1.9M | — | 0.32% | EC |
| 72 | Protagonist Therapeutics Inc | PTGX | Apr 2024 | 40,043 | -146,852 | $1.8M | -60.9% | 0.30% | EC |
| 73 | Kymera Therapeutics Inc | KYMR | Apr 2024 | 53,385 | -111,365 | $1.8M | -67.0% | 0.30% | EC |
| 74 | Vera Therapeutics Inc. | VERA | Apr 2024 | 76,809 | -59,745 | $1.8M | -66.7% | 0.30% | EC |
| 75 | Amicus Therapeutics Inc. | FOLD | Apr 2024 | 229,620 | -352,903 | $1.8M | -69.7% | 0.29% | EC |
| 76 | Dynavax Technologies Corp. | DVAX | Apr 2024 | 148,736 | -396,541 | $1.7M | -71.8% | 0.29% | EC |
| 77 | CG Oncology Inc. | CGON | Apr 2025 | 64,639 | New | $1.7M | — | 0.29% | EC |
| 78 | Janux Therapeutics Inc | JANX | Apr 2025 | 50,933 | New | $1.7M | — | 0.28% | EC |
| 79 | Novavax Inc | NVAX | Apr 2024 | 251,302 | -1,063,370 | $1.7M | -70.6% | 0.28% | EC |
| 80 | Vericel Corporation | VCEL | Apr 2024 | 43,162 | -91,507 | $1.6M | -73.4% | 0.27% | EC |
| 81 | Dyne Therapeutics Inc. | DYN | Apr 2024 | 133,339 | -135,731 | $1.6M | -76.9% | 0.26% | EC |
| 82 | Apogee Therapeutics Inc. | APGE | Apr 2024 | 38,909 | -12,760 | $1.5M | -41.2% | 0.25% | EC |
| 83 | Disc Medicine Inc | IRON | Apr 2024 | 30,798 | -49,566 | $1.5M | -32.0% | 0.25% | EC |
| 84 | Caredx Inc | CDNA | Apr 2024 | 89,883 | -195,132 | $1.5M | -31.4% | 0.25% | EC |
| 85 | Intellia Therapeutics Inc | NTLA | Apr 2024 | 162,953 | -76,118 | $1.4M | -71.7% | 0.24% | EC |
| 86 | Iovance Biotherapeutics Inc | IOVA | Apr 2024 | 381,437 | -74,935 | $1.4M | -74.5% | 0.23% | EC |
| 87 | Viridian Therapeutics Inc | VRDN | Apr 2024 | 95,820 | -223,645 | $1.3M | -69.4% | 0.22% | EC |
| 88 | Mannkind Corporation | MNKD | Apr 2024 | 238,837 | -333,162 | $1.2M | -48.8% | 0.20% | EC |
| 89 | Nurix Therapeutics Inc. | NRIX | Apr 2024 | 99,617 | -65,569 | $1.1M | -42.2% | 0.19% | EC |
| 90 | Geron Corp. | GERN | Apr 2024 | 797,756 | -1,086,137 | $1.1M | -84.8% | 0.19% | EC |
| 91 | Uniqure N.V. | QURE | Apr 2025 | 74,743 | New | $1.1M | — | 0.18% | EC |
| 92 | Anavex Life Sciences Corp. | AVXL | Apr 2024 | 115,333 | -408,100 | $1.1M | -42.7% | 0.18% | EC |
| 93 | Rocket Pharmaceuticals Inc | RCKT | Apr 2024 | 141,040 | -116,047 | $1.1M | -80.5% | 0.18% | EC |
| 94 | Praxis Precision Medicines Inc | PRAX UW | Apr 2025 | 26,465 | New | $996K | — | 0.17% | EC |
| 95 | 89bio Inc. | ETNB | Apr 2024 | 124,191 | -236,741 | $996K | -67.6% | 0.17% | EC |
| 96 | Myriad Genetics Inc. | MYGN | Apr 2024 | 132,844 | -61,860 | $984K | -74.2% | 0.16% | EC |
| 97 | Spyre Therapeutics Inc | SYRE | Apr 2025 | 63,626 | New | $969K | — | 0.16% | EC |
| 98 | Capricor Therapeutics Inc | CAPR UR | Apr 2025 | 75,105 | New | $954K | — | 0.16% | EC |
| 99 | ARS Pharmaceuticals Inc | SPRY | Apr 2024 | 68,164 | -18,996 | $952K | +25.6% | 0.16% | EC |
| 100 | VIR Biotechnology Inc | VIR | Apr 2024 | 154,852 | -188,394 | $948K | -67.4% | 0.16% | EC |
| 101 | Arcus Biosciences Inc. | RCUS | Apr 2024 | 101,639 | -163,749 | $889K | -78.0% | 0.15% | EC |
| 102 | Xencor Inc | XNCR | Apr 2024 | 78,495 | -100,713 | $865K | -76.9% | 0.14% | EC |
| 103 | Day One Biopharmaceuticals Inc. | DAWN | Apr 2024 | 107,832 | -43,137 | $839K | -67.5% | 0.14% | EC |
| 104 | Immunome Inc | IMNM | Apr 2025 | 92,724 | New | $815K | — | 0.14% | EC |
| 105 | Cogent Biosciences Inc. | COGT | Apr 2024 | 151,723 | -398,981 | $790K | -77.9% | 0.13% | EC |
| 106 | Kura Oncology Inc. | KURA | Apr 2024 | 118,638 | -124,559 | $778K | -83.7% | 0.13% | EC |
| 107 | ImmunityBio Inc | IBRX | Apr 2024 | 293,683 | -730,134 | $737K | -91.0% | 0.12% | EC |
| 108 | Keros Therapeutics Inc. | KROS | Apr 2024 | 50,062 | -43,317 | $723K | -86.3% | 0.12% | EC |
| 109 | Replimune Group Inc | REPL | Apr 2024 | 71,127 | -430,534 | $696K | -78.2% | 0.12% | EC |
| 110 | Altimmune Inc. | ALT UQ | Apr 2024 | 130,009 | -559,595 | $683K | -84.9% | 0.11% | EC |
| 111 | AnaptysBio Inc. | ANAB | Apr 2024 | 28,201 | -42,652 | $627K | -63.7% | 0.10% | EC |
| 112 | Relay Therapeutics Inc | RLAY | Apr 2024 | 185,555 | -177,021 | $618K | -73.9% | 0.10% | EC |
| 113 | Verve Therapeutics Inc | VERV | Apr 2024 | 101,889 | -235,300 | $578K | -71.5% | 0.10% | EC |
| 114 | Arcturus Therapeutics Holdings Inc | ARCT | Apr 2024 | 44,774 | -77,569 | $574K | -81.7% | 0.10% | EC |
| 115 | Stoke Therapeutics Inc | STOK | Apr 2025 | 55,834 | New | $545K | — | 0.09% | EC |
| 116 | Emergent Biosolutions Inc | EBS | Apr 2025 | 100,539 | New | $537K | — | 0.09% | EC |
| 117 | Dianthus Therapeutics Inc | DNTH | Apr 2025 | 21,600 | New | $472K | — | 0.08% | EC |
| 118 | Akebia Therapeutics Inc. | AKBA | Apr 2025 | 186,979 | New | $451K | — | 0.07% | EC |
| 119 | Cullinan Therapeutics Inc | CGEM | Apr 2024 | 49,727 | -26,108 | $412K | -79.9% | 0.07% | EC |
| 120 | MiMedx Group Inc. | MDXG | Apr 2024 | 59,325 | -165,906 | $408K | -70.6% | 0.07% | EC |
| 121 | ORIC Pharmaceuticals Inc. | ORIC | Apr 2024 | 70,061 | -16,782 | $400K | -47.8% | 0.07% | EC |
| 122 | Rigel Pharmaceuticals Inc. | RIGL UW | Apr 2025 | 19,354 | New | $379K | — | 0.06% | EC |
| 123 | Prothena Corporation PLC | PRTA | Apr 2024 | 39,785 | -197,304 | $366K | -92.4% | 0.06% | EC |
| 124 | Sana Biotechnology Inc | SANA | Apr 2024 | 176,560 | -210,918 | $335K | -90.4% | 0.06% | EC |
| 125 | ArriVent BioPharma Inc. | AVBP | Apr 2025 | 15,761 | New | $335K | — | 0.06% | EC |
| 126 | KalVista Pharmaceuticals Inc. | KALV | Apr 2025 | 23,768 | New | $327K | — | 0.05% | EC |
| 127 | Arbutus Biopharma Corp. | ABUS | Apr 2025 | 74,980 | New | $266K | — | 0.04% | EC |
| 128 | Humacyte Inc. | HUMA | Apr 2025 | 167,406 | New | $243K | — | 0.04% | EC |
| 129 | Organogenesis Holdings Inc. | ORGO | Apr 2025 | 28,951 | New | $142K | — | 0.02% | EC |
| 130 | Scilex Holding Co | SCLX UR | Apr 2025 | 17,718 | New | $84K | — | 0.01% | EC |
| 131 | INHIBRX INC CVR | 457CVR017 | Apr 2025 | 164,173 | New | $0 | — | 0.00% | EC |
| 132 | OmniAb Inc. | 2200963D | Apr 2024 | 14,783 | — | $0 | — | 0.00% | EC |
| 133 | OmniAb Inc. | 2200964D | Apr 2024 | 14,783 | — | $0 | — | 0.00% | EC |
| 134 | N/A | N/A | Apr 2024 | 1 | New | $-3515594 | — | -0.58% | DE |
| 135 | N/A | N/A | Apr 2024 | 1 | New | $-16696463 | — | -2.77% | DE |
| 136 | N/A | N/A | Apr 2024 | 1 | New | $-16798881 | — | -2.79% | DE |
| 137 | N/A | N/A | Apr 2024 | 1 | New | $-27092639 | — | -4.49% | DE |
| 138 | N/A | N/A | Apr 2024 | 1 | New | $-28491478 | — | -4.73% | DE |
| ✕ | Alpine Immune Sciences Inc | 02083G100 | — | 183,314 | Exited | $11.8M | — | — | — |
| ✕ | Cerevel Therapeutics Holdings Inc | 15678U128 | — | 173,690 | Exited | $7.4M | — | — | — |
| ✕ | Ironwood Pharmaceuticals, Inc. | 46333X108 | — | 795,227 | Exited | $6.2M | — | — | — |
| ✕ | Inhibrx Inc. | 45720L107 | — | 157,786 | Exited | $5.4M | — | — | — |
| ✕ | Morphic Holding Inc. | 61775R105 | — | 172,507 | Exited | $4.7M | — | — | — |
| ✕ | Deciphera Pharmaceuticals Inc | 24344T101 | — | 170,510 | Exited | $4.3M | — | — | — |
| ✕ | Sage Therapeutics Inc | 78667J108 | — | 306,610 | Exited | $4.3M | — | — | — |
| ✕ | C4 Therapeutics Inc | 12529R107 | — | 651,358 | Exited | $4.1M | — | — | — |
| ✕ | Macrogenics Inc | 556099109 | — | 275,565 | Exited | $4.1M | — | — | — |
| ✕ | Biomea Fusion Inc | 09077A106 | — | 373,747 | Exited | $4.0M | — | — | — |
| ✕ | Editas Medicine Inc | 28106W103 | — | 629,638 | Exited | $3.3M | — | — | — |
| ✕ | Avid Bioservices Inc. | 05368M106 | — | 410,646 | Exited | $3.1M | — | — | — |
| ✕ | Cabaletta Bio Inc | 12674W109 | — | 276,913 | Exited | $2.9M | — | — | — |
| ✕ | 4D Molecular Therapeutics Inc | 35104E100 | — | 121,536 | Exited | $2.9M | — | — | — |
| ✕ | Zentalis Pharmaceuticals Inc | 98943L107 | — | 232,838 | Exited | $2.6M | — | — | — |
| ✕ | Olema Pharmaceuticals Inc. | 68062P106 | — | 230,264 | Exited | $2.3M | — | — | — |
| ✕ | Fate Therapeutics Inc. | 31189P102 | — | 570,082 | Exited | $2.3M | — | — | — |
| ✕ | Regenxbio Inc. | 75901B107 | — | 140,529 | Exited | $2.2M | — | — | — |
| ✕ | Kiniksa Pharmaceuticals Ltd. | G5269C101 | — | 110,056 | Exited | $2.1M | — | — | — |
| ✕ | Allogene Therapeutics Inc | 019770106 | — | 613,905 | Exited | $1.7M | — | — | — |
| ✕ | Caribou Biosciences Inc | 142038108 | — | 423,044 | Exited | $1.5M | — | — | — |
| ✕ | Tango Therapeutics Inc. | 87583X109 | — | 171,902 | Exited | $1.3M | — | — | — |
| ✕ | Astria Therapeutics Inc | 04635X102 | — | 122,301 | Exited | $1.1M | — | — | — |
| ✕ | Alector Inc | 014442107 | — | 215,351 | Exited | $1.1M | — | — | — |
| ✕ | Mersana Therapeutics Inc | 59045L106 | — | 287,856 | Exited | $0.9M | — | — | — |
| ✕ | Voyager Therapeutics Incorporation | 92915B106 | — | 93,149 | Exited | $0.7M | — | — | — |
| ✕ | Cargo Therapeutics Inc | 14179K101 | — | 37,180 | Exited | $0.7M | — | — | — |
| ✕ | Scilex Holding Co | 80880W106 | — | 620,131 | Exited | $0.5M | — | — | — |
| ✕ | Avita Medical Inc. | 05380C102 | — | 40,315 | Exited | $0.3M | — | — | — |